the use of the adapted myeloma cells ( ns-1-503 ) , instead of ns-1 myeloma cells , in fusion experiments not only permitted the isolation of antibody-secreting hybridomas in lipid-free kslm medium but also resulted in a higher yield of antibody-producing hybridomas in both complete kslm medium and serum-supplemented medium .
C0007634
the
C1327616
secreting